Walker K, Frazee R, Roberts J
Department of Surgery, Scott and White Clinic, Texas A&M University College of Medicine, Temple.
Am Surg. 1992 Jul;58(7):409-12.
A review of 52 patients with gastric lymphoma at the Texas A&M University College of Medicine Affiliated Scott and White Memorial Hospital (Temple, TX). was performed to determine the influence of different treatment modalities. Thirty-one patients had a potentially curative resection, while 21 underwent a palliative procedure or biopsy alone. Overall 5-year survival was 73.4 per cent after curative resection and 38.3 per cent for lesser operative procedures (P less than .005). Adjuvant radiation was given to 14 patients after curative resection with a 5-year survival rate of 71.5 per cent compared to 82.4 per cent in the 17 patients treated by curative resection alone (nonsignificant). Patients who underwent palliative surgery or biopsy who received postoperative radiation therapy had a 38.0 per cent 5-year survival rate compared to a 0.0 per cent 5-year survival rate in patients who received no therapy (P = .18). The authors conclude that curative resection is the treatment of choice for gastric lymphoma, but radiation therapy may offer some benefit when complete resection is not feasible.
对德克萨斯农工大学医学院附属斯科特与怀特纪念医院(德克萨斯州坦普尔)的52例胃淋巴瘤患者进行了回顾性研究,以确定不同治疗方式的影响。31例患者接受了可能治愈性的切除术,而21例仅接受了姑息性手术或活检。治愈性切除术后的总体5年生存率为73.4%,较小手术操作后的5年生存率为38.3%(P<0.005)。14例患者在治愈性切除术后接受了辅助放疗,其5年生存率为71.5%,而仅接受治愈性切除术的17例患者的5年生存率为82.4%(无统计学意义)。接受姑息性手术或活检并接受术后放疗的患者5年生存率为38.0%,而未接受治疗的患者5年生存率为0.0%(P = 0.18)。作者得出结论,治愈性切除是胃淋巴瘤的首选治疗方法,但当无法进行完全切除时,放疗可能会带来一些益处。